[Pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field. Pediatric Study Group of ME1207].

Author: FujiiR, FujitaK, FukushimaN, IsekiK, MaruyamaS, MuronoK, OkunoA, SakataH, WagatsumaY, YoshiokaH

Paper Details 
Original Abstract of the Article :
Cefditoren pivoxil (ME1207) in granules, a new oral cephalosporin, was pharmacokinetically and clinically evaluated in the pediatric field and the following results were obtained: 1. Pharmacokinetics In infants administered single oral doses of 3 mg (potency)/kg and 6 mg/kg, the Cmax was 1.54 +/- 0....See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/8455336

データ提供:米国国立医学図書館(NLM)

Cefditoren Pivoxil: A New Hope for Pediatric Infections

Cefditoren pivoxil, a novel oral cephalosporin, has shown promising results in treating various infections in children. This study evaluates the pharmacokinetic properties and clinical efficacy of cefditoren pivoxil in a large pediatric population.

Cefditoren Pivoxil: Effective and Safe for Children

The study found that cefditoren pivoxil was well-tolerated by children, with a favorable safety profile and a high overall clinical efficacy rate (97.3%). The drug exhibited a dose-dependent pharmacokinetic behavior, achieving peak concentrations in the urine within 2-4 hours after administration. The high bacteriological eradication rate (90.4%) further supports its effectiveness in combating infections.

Protecting Children's Health: Choosing the Right Antibiotic

This research highlights the importance of choosing the right antibiotic for children, taking into account their individual needs and the specific infection. Cefditoren pivoxil, with its favorable safety profile and efficacy, presents a valuable option for treating various pediatric infections.

Dr. Camel's Conclusion

This study provides strong evidence for the efficacy and safety of cefditoren pivoxil in treating pediatric infections. The findings are a testament to the progress made in developing effective and safe antibiotic therapies for children, a vital step in ensuring their health and well-being. This research, like a camel caravan crossing the desert, carries the promise of a brighter future for children facing infections.

Date :
  1. Date Completed 1993-04-21
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

8455336

DOI: Digital Object Identifier

8455336

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.